Zacks Investment Research AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near...\n more…
Seeking Alpha - Healthcare Abbvie's Botox launches for wide jaw appearance in China...\n more…
FierceBiotech.com - Biotech AbbVie slaps BeiGene with another blood cancer lawsuit, this time on BTK degrader trade secrets\nfkansteiner\nWed, 09/11/2024 - 10:21...\n more…
Ticker Report LGT Fund Management Co Ltd. purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm...\n more…